Protein Summary
Regulates central hypertension through its calcium-modulated preference to cleave N-terminal acidic residues from peptides such as angiotensin II.
- ENST00000265162
- ENSP00000265162
- ENSG00000138792
- APA
- CD249
- gp160
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
disease perturbation | 0.79 | ||
gene perturbation | 0.76 | ||
cellular component | 0.71 | ||
kinase perturbation | 0.71 | ||
transcription factor perturbation | 0.68 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 966.3 (req: < 5)
Gene RIFs: 20 (req: <= 3)
Antibodies: 456 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 966.3 (req: >= 5)
Gene RIFs: 20 (req: > 3)
Antibodies: 456 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 14
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 45
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0